Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy

Background: Some studies of dual-targeted therapy (DTT) targeting epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition (MET) have shown promising efficacy in non-small-cell lung cancer (NSCLC). Consequently, patient management following DTT resistance has gained significance...

Full description

Bibliographic Details

Published in:	Therapeutic Advances in Medical Oncology
Main Authors:	Mei-Mei Fang, Jiang-Tao Cheng, Yu-Qing Chen, Xiao-Cheng Lin, Jun-Wei Su, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-03-01
Online Access:	https://doi.org/10.1177/17588359241234504